cjc-1295 + ipamorelin dosage in units CJC-1295/Ipamorelin Dosage: Dosing & Cycle Guide CJC-1295 + Ipamorelin Dosage Guide:

Effects are pronounced relative to other interventions in some metrics but modest in absolute magnitude

Trial evidence: Tesamorelin 2mg SC daily sustained GH/IGF-1 elevation, 15-18% visceral fat reduction over 6 months (Falutz, NEJM 2007, PMID 17699044) Ipamorelin 200-300 mcg peak GH 5-10x baseline within 30 minutes, no cortisol/prolactin bump (Raun, EJE 1998, PMID 9539826) GHRH + GHRP synergy 2-3x greater amplitude than either alone (Bowers, JCEM 1991, PMID 2004615) Community protocols extend this evidence base with cycling patterns that weren't studied in the original trials the 5-on/2-off rhythm and 8-week cycles are empirical community consensus, not clinically validated

Some of the side effects observed were nausea/vomiting, dizziness, malaise, and sweating (47)

Additionally, researchers observed a notable increase in the thickness of the epidermal layer, which might indicate an influence of elevated growth hormone levels on epidermal cell proliferation